Replies to post #125771 on Biotech Values

[DewDiligence]

Appellate court upholds $442M award of patent-infringement damages against Apotex in generic-Plavix case:

http://www.bloomberg.com/news/2011-10-18/bristol-myers-sanofi-442-million-plavix-award-upheld-on-appeal.html

The amount would have been much higher if BMY/SNY and Apotex had not inked a side agreement limiting Apotex’s damages to 50% of the economic harm caused by the patent infringement (#msg-13046621, #msg-12797613).

[DewDiligence]

Cases Where a Preliminary Injunction Blocked the Launch of a Generic Drug

[Added Lovenox entry.]

  
 Drug       Plaintiff  Defendant      Date  iHub reference  
 Accupril   PFE        Teva/Ranbaxy   3/05  #msg-5901380 
 Evista     LLY        Teva           4/09  #msg-37243180 
 Fentora    CEPH       WPI            6/08  #msg-61335088 
 Lovenox    MNTA/NVS   Amphastar/WPI 10/11  #msg-68468217 
 Mircera    AMGN       Roche          4/08  #msg-28360600 
 Oracea     Galderma   MYL            7/10  #msg-66590889 
 Plavix     SNY/BMY    Apotex         9/06  #msg-13221959